During the past decade, Desert Regional Medical Center Comprehensive Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 19 clinical trials were completed, i.e. on average, 271.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Desert Regional Medical Center Comprehensive Cancer Center" #1 sponsor was "SWOG Cancer Research Network" with 12 trials, followed by "NSABP Foundation Inc" with 10 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored, "CancerVax Corporation" with 3 trials sponsored and "Cephalon" with 3 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Desert Regional Medical Center Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Desert Regional Medical Center Comprehensive Cancer Center" are "Breast Cancer" (22 trials), "Multiple Myeloma" (4 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials) and "Lymphoma" (3 trials). Many other conditions were trialed in "Desert Regional Medical Center Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Desert Regional Medical Center Comprehensive Cancer Center" are "Drug" (55 trials), "Biological" (16 trials), "Procedure" (8 trials), "Radiation" (7 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "Placebo" (5 trials), "oxaliplatin" (5 trials), "Cyclophosphamide" (4 trials) and "cetuximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Desert Regional Medical Center Comprehensive Cancer Center" are 43 trials for "All" genders, 23 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Desert Regional Medical Center Comprehensive Cancer Center". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Desert Regional Medical Center Comprehensive Cancer Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Desert Regional Medical Center Comprehensive Cancer Center, 7 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".